Cross Country Healthcare, Inc. (CCRN)
Jul 21, 2026 - CCRN was delisted (reason: acquired by Knox Lane)
13.25
0.00 (0.00%)
Inactive · Last trade price on Jul 20, 2026
Cross Country Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,002 | 1,054 | 1,344 | 2,020 | 2,803 | 1,677 | |
Revenue Growth | -20.37% | -21.56% | -33.46% | -27.95% | 67.20% | 100.46% |
Cost of Revenue | 799.44 | 840.72 | 1,070 | 1,569 | 2,179 | 1,302 |
Gross Profit | 202.5 | 213.57 | 274.25 | 450.41 | 624.46 | 375 |
Selling, General & Admin | 188.01 | 194.68 | 233.38 | 300.33 | 324.21 | 215.26 |
Other Operating Expenses | - | - | 1.97 | 1.13 | - | - |
Operating Expenses | 203.28 | 211.03 | 274.98 | 334.37 | 346.39 | 229.9 |
Operating Income | -0.78 | 2.54 | -0.73 | 116.04 | 278.06 | 145.1 |
Interest Expense | -2.24 | -2.22 | -2.19 | -8.09 | -14.39 | -6.87 |
Interest & Investment Income | 3.42 | 3.13 | 2.05 | 0.08 | 0.01 | - |
Other Non Operating Income (Expenses) | 0.07 | -0.01 | 0.61 | -0.09 | 1.33 | 0.77 |
EBT Excluding Unusual Items | 0.47 | 3.44 | -0.26 | 107.95 | 265.01 | 139.01 |
Merger & Restructuring Charges | 1.23 | -0.35 | -11.44 | -2.61 | -2.59 | -3.73 |
Impairment of Goodwill | -71.26 | -71.26 | - | - | - | - |
Asset Writedown | -6.83 | -6.59 | - | -0.72 | -5.6 | -2.07 |
Legal Settlements | -3.96 | -2.75 | -4.7 | - | - | - |
Other Unusual Items | -6 | -6 | - | -1.72 | -3.73 | - |
Pretax Income | -86.35 | -83.51 | -16.4 | 102.89 | 253.1 | 133.21 |
Income Tax Expense | 12.28 | 11.34 | -1.84 | 30.26 | 67.12 | 1.21 |
Earnings From Continuing Operations | -98.63 | -94.85 | -14.56 | 72.63 | 185.98 | 132 |
Net Income | -98.63 | -94.85 | -14.56 | 72.63 | 185.98 | 132 |
Net Income to Common | -98.63 | -94.85 | -14.56 | 72.63 | 185.98 | 132 |
Net Income Growth | - | - | - | -60.95% | 40.89% | - |
Shares Outstanding (Basic) | 32 | 32 | 33 | 35 | 37 | 37 |
Shares Outstanding (Diluted) | 32 | 32 | 33 | 35 | 38 | 37 |
Shares Change | -2.10% | -2.91% | -5.91% | -5.49% | 0.39% | 3.61% |
EPS (Basic) | -3.06 | -2.93 | -0.44 | 2.07 | 5.02 | 3.60 |
EPS (Diluted) | -3.07 | -2.93 | -0.44 | 2.05 | 4.95 | 3.53 |
EPS Growth | - | - | - | -58.59% | 40.23% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 39.6 | 40.09 | 111.4 | 234.52 | 125.26 | -92.79 |
Free Cash Flow Per Share | 1.23 | 1.24 | 3.34 | 6.61 | 3.34 | -2.48 |
Gross Margin | 20.21% | 20.26% | 20.41% | 22.30% | 22.27% | 22.37% |
Operating Margin | -0.08% | 0.24% | -0.05% | 5.75% | 9.92% | 8.65% |
Profit Margin | -9.84% | -9.00% | -1.08% | 3.60% | 6.63% | 7.87% |
Free Cash Flow Margin | 3.95% | 3.80% | 8.29% | 11.61% | 4.47% | -5.53% |
EBITDA | 14.11 | 18.53 | 16.78 | 133.89 | 290.04 | 154.56 |
EBITDA Margin | 1.41% | 1.76% | 1.25% | 6.63% | 10.35% | 9.22% |
D&A For EBITDA | 14.89 | 15.99 | 17.5 | 17.85 | 11.98 | 9.45 |
EBIT | -0.78 | 2.54 | -0.73 | 116.04 | 278.06 | 145.1 |
EBIT Margin | -0.08% | 0.24% | -0.05% | 5.75% | 9.92% | 8.65% |
Effective Tax Rate | - | - | - | 29.41% | 26.52% | 0.91% |
Advertising Expenses | - | 7.5 | 8.5 | 11.5 | 16.1 | 9.5 |